Application 203611
- Type
- ANDA
- Sponsor
- ACTAVIS ELIZABETH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | TABLET; ORAL | 300MG | No | No |
| 002 | GABAPENTIN | GABAPENTIN | TABLET; ORAL | 600MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203611-001 | GABAPENTIN | GABAPENTIN | 300MG | TABLET / ORAL | AB2 | 2026-06-23 | |
| A203611-002 | GABAPENTIN | GABAPENTIN | 600MG | TABLET / ORAL | AB2 | 2026-06-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203611-001 | AB2 |
| A203611-002 | AB2 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A203611-001 | GABAPENTIN | 300MG | TABLET / ORAL | AB2 | 2026-06-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A203611-002 | GABAPENTIN | 600MG | TABLET / ORAL | AB2 | 2026-06-23 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A203611-001 | GABAPENTIN | 300MG | TABLET / ORAL | AB2 | 2026-06-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A203611-002 | GABAPENTIN | 600MG | TABLET / ORAL | AB2 | 2026-06-23 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203611-001 | GABAPENTIN | 300MG | TABLET / ORAL | AB2 | 2026-06-23 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203611-002 | GABAPENTIN | 600MG | TABLET / ORAL | AB2 | 2026-06-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A203611-001 | AB2 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A203611-002 | AB2 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A203611-001 | AB2 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A203611-002 | AB2 | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203611-001 | AB2 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A203611-002 | AB2 | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Proficient Rx LP | 223a9216-6e07-49b9-8faf-bb4e529a6ae5 | 2022-04-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 2fb2233f-9152-4630-ab39-51a0cda7e5ca | 2022-04-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 52af51ab-6543-466b-848c-13c588c98789 | 2022-04-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 2b76955c-52a4-4026-b286-3da1112fe989 | 2022-04-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 7790d906-af26-4e60-bc6f-e906ec03cc24 | 2022-03-21 | Warnings, Adverse reactions | gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 7f579665-afb7-4227-98c1-2eafee650504 | 2022-02-28 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 185f264e-db32-41cd-b90d-519717b97850 | 2021-11-01 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals of New York LLC | b11dbff5-ceee-4a63-a093-f6efebdc2f6f | 2021-02-03 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | f6baeb5c-ca9c-4730-aeb8-8f8732e8ca3a | 2021-01-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | c79d94ec-117d-4fb6-845d-1954e3472bb0 | 2021-01-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gaba 300-EZS | GABAPENTIN | PureTek Corporation | bb29692e-1546-4d05-a46a-93baf4172c7d | 2020-11-16 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 3b4395f2-9440-4b67-97cc-5d16f3bdd05e | 2020-08-14 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 39149f0e-30ed-4671-8be7-2a484f65d63b | 2020-08-05 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | ded42b88-94dd-462d-bcdf-7fd34d1e49c3 | 2020-07-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Asclemed USA, Inc. | 45039bba-7a96-450c-95be-83a3aa4fcbd2 | 2020-06-10 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 8b2f38ef-0a0c-45cc-88ca-cc086bf80641 | 2020-06-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | ba2a8352-5776-4edb-914e-ce1d18ccda32 | 2020-05-27 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | c09c66fd-cb31-41dd-b00b-acc58bd809f7 | 2020-01-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 7d77dae0-df76-4b7b-9690-713e9a60e3cd | 2019-12-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 4bae5032-f634-4d1e-b672-8a7e2bd6a5fa | 2019-11-01 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.